I appreciate it Gary. But I've got a line on some info regarding a certain solid tumor biomarker that was identified in P2 and has been leaked from the Israeli site in P3 that Multikine is nearly 100% effective on. Mathematically speaking, OS should come in around 18% but more importantly several of the secondary endpoints will SHINE. The trail design is such that the secondary endpoints alone should garner approval.